169 related articles for article (PubMed ID: 32345252)
21. Laser and ranibuzumab combination for retinal vasoproliferative tumor's management.
Fernández-Martínez C; Martínez-Toldos JJ; Hernández-Artola F
Arch Soc Esp Oftalmol; 2015 Dec; 90(12):593-6. PubMed ID: 26347320
[TBL] [Abstract][Full Text] [Related]
22. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
Stathopoulos C; Gaillard MC; Moulin A; Puccinelli F; Beck-Popovic M; Munier FL
Retina; 2019 Dec; 39(12):2273-2282. PubMed ID: 30312257
[TBL] [Abstract][Full Text] [Related]
23. Neovascular glaucoma after branch retinal artery occlusion.
Yamamoto K; Tsujikawa A; Hangai M; Fujihara M; Iwawaki T; Kurimoto Y
Jpn J Ophthalmol; 2005; 49(5):388-90. PubMed ID: 16187039
[TBL] [Abstract][Full Text] [Related]
24. Neovascular glaucoma as a complication of retinal vasculitis in Crohn disease.
Salmon JF; Ursell PG; Frith P
Am J Ophthalmol; 2000 Oct; 130(4):528-30. PubMed ID: 11024432
[TBL] [Abstract][Full Text] [Related]
25. Expression of platelet-derived growth factor-C in aqueous humor of patients with neovascular glaucoma and its correlation with vascular endothelial growth factor.
Li Y; Hu D; Lv P; Xing M; Song Z; Li C; Wang Y; Hou X
Eur J Ophthalmol; 2020 May; 30(3):500-505. PubMed ID: 30803266
[TBL] [Abstract][Full Text] [Related]
26. Retinal vasoproliferative tumour-induced intractable neovascular glaucoma in a child with neurofibromatosis type 1.
C Parameswarappa D; Alone AA; Rani PK
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32847892
[No Abstract] [Full Text] [Related]
27. Coats' disease and neovascular glaucoma in a child with neurofibromatosis.
Chiu SL; Chen SN; Chen YT; Chen PJ
J Pediatr Ophthalmol Strabismus; 2011; 48 Online():e1-3. PubMed ID: 20210281
[TBL] [Abstract][Full Text] [Related]
28. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
29. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
[TBL] [Abstract][Full Text] [Related]
30. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
Wasik A; Song HF; Grimes A; Engelke C; Thomas A
Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
[TBL] [Abstract][Full Text] [Related]
31. [Neurofibromatosis type 1 initially presented with glaucoma in the Department of Ophthalmology: a case report].
Yan HX; Fei F; Hu D; Zhou J; Li MH; Zhang ZF; Wang YS
Zhonghua Yan Ke Za Zhi; 2022 May; 58(5):373-375. PubMed ID: 35511664
[TBL] [Abstract][Full Text] [Related]
32. Management of neovascular glaucoma with intravitreal ranibizumab, panretinal photocoagulation, and subsequent 5-fluorouracil augmented trabeculectomy: A case report.
Zhao X; Wang Z; Yang X
Medicine (Baltimore); 2017 Jun; 96(25):e7221. PubMed ID: 28640115
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.
Kim M; Lee C; Payne R; Yue BY; Chang JH; Ying H
Surv Ophthalmol; 2015; 60(6):524-35. PubMed ID: 25980779
[TBL] [Abstract][Full Text] [Related]
34. Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.
Witkin AJ; Shah AR; Engstrom RE; Kron-Gray MM; Baumal CR; Johnson MW; Witkin DI; Leung J; Albini TA; Moshfeghi AA; Batlle IR; Sobrin L; Eliott D
Ophthalmology; 2015 Jul; 122(7):1438-51. PubMed ID: 25886796
[TBL] [Abstract][Full Text] [Related]
35. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
[TBL] [Abstract][Full Text] [Related]
36. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
[TBL] [Abstract][Full Text] [Related]
37. Bilateral neovascular glaucoma in idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome.
Sinha G; Nayak B; Gupta S; Gupta V
Can J Ophthalmol; 2016 Apr; 51(2):e43-5. PubMed ID: 27085273
[No Abstract] [Full Text] [Related]
38. Neovascular Glaucoma in Children: A case series and a review of the literature.
Nieves-Moreno M; Peralta J; Noval S
Eur J Ophthalmol; 2022 Nov; 32(6):3289-3294. PubMed ID: 35132889
[TBL] [Abstract][Full Text] [Related]
39. A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration.
Jaffe GJ; Eliott D; Wells JA; Prenner JL; Papp A; Patel S
Ophthalmology; 2016 Jan; 123(1):78-85. PubMed ID: 26499921
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of retinopathy of incontinentia pigmenti by anti-vascular endothelial growth factor].
Wang X; Liang JH
Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):294-301. PubMed ID: 30982292
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
